Supportive Care for
the Cancer Patient

Webcast CME Disclosure

Please read this notice and click the acknowledgement
at the bottom of the page to continue.

Release Date:

June 8, 2009

Expiration Date:

June 8, 2011

Intended Audience:

The program is designed for all clinicians, program directors, nurses, and pharmacists providing care for patients with cancer. Physician, nursing, and pharmacist specialists from the disciplines of oncology, hematology, thrombosis medicine, supportive care, cancer nursing, primary care, and clinical pharmacy are invited to attend.

Registration:

Enrollment for this WebCAST is complimentary, and clinicians are invited to participate in this CME-certified HealthWRAPs and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support:

The following program has been supported
by an independent medical educational grant
from Eisai, Inc.

Accreditation Statement:

This activity has been planned and implemented in accordance with the Essentials Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Massachusetts Medical School and CMEducation Resources, LLC. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The University of Massachusetts Medical School designates this educational activity for a maximum of 3 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure:

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Policy on Faculty Disclosure

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Program Faculty and Disclosures:

Craig M. Kessler, MD - Co-Chairman
Professor of Medicine and Pathology
Georgetown University Medical Center
Lombardi Comprehensive Cancer Center
Chief, Division of Coagulation
Washington, DC

Grant/Research Support: GlaxoSmithKline
Consultant: Sanofi-Aventis, Eisai Pharmaceuticals
Speaker’s Bureau: Sanofi-Aventis, GlaxoSmithKline

Steven Grunberg, MD - Co-Chairman
Professor of Medicine
University of Vermont
Burlington, VT

Grant/Research: Merck
Consultant: Merck, GlaxoSmithKline
Speaker’s Bureau: Merck, Eisai

Charles Loprinzi, MD
Professor of Oncology
Director, NCCTG Cancer Control Program
Co-Director Mayo Cancer Center Cancer Prevention and Control Program
Mayo Clinic
Rochester, MN

No information to disclose

Educational Objectives:

As a result of participating in this program, clinicians from multiple disciplines, including oncology, hematology, surgical oncology, cancer supportive care, cancer nursing, internal medicine, clinical pharmacy, and related specialties will:

• Learn about the prevalence and incidence of CINV in the setting of tumors across the cancer treatment and disease state spectrum.
• Learn about causes and treatment approaches to peripheral neuropathy.
• Learn to risk stratify cancer patients, evaluate their likelihood for incurring DVT, and learn how to assess and implement prophylaxis measures that can reduce the incidence of DVT in these patient populations.
• Learn how to apply current guidelines for pharmacologic prophylaxis of DVT issued by national professional organizations (ASCO, NCCN, ACCP, ASHP) in at-risk patients with cancer, medical and surgical conditions.
• Learn how to employ a “cancer supportive care” team approach, with oncologists, oncology nurses, and supportive care personnel to optimize management of CINV in both acute and delayed phases.

Disclaimer:

Copyright © 2009 by CMEducation Resources, LLC and Pharmatecture, LLC All rights reserved. Reproduction, distribution, or translation without express written permission is strictly prohibited.

Content on this HealthWRAP reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.

Content on this HealthWRAP is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.

Content on this HealthWRAP is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This HealthWRAP is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This HealthWRAP is not intended for use by the layman.

Opinions expressed herein are not necessarily those of CMEducation Resources, LLC, Pharmatecture, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

Copyright © 2009 All rights reserved